Vertex Pharmaceuticals Inc
Close on Nov 3, 2026Market cap $134.53BP/E 30.9Yield –
Vertex Pharmaceuticals Vertex Europe (UK) by Year
Vertex Europe (UK) — Non-current lease liabilities ($M) ($M)
Vertex Pharmaceuticals Vertex Europe (UK): $110M in FY2025, down 4.1% from a year earlier.
Where the FY2025 figure comes from
“Lease liabilities 20 (110,177) (114,892)”
Source: Vertex Pharmaceuticals (Europe) Limited (02907620) ↗
Reported in UK Companies House Statutory Accounts (02907620, OCR).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Vertex Europe (UK) — Non-current lease liabilities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 110 | -4.1% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2024 | Dec 31, 2024 | 115 | +283.0% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2023 | Dec 31, 2023 | 30 | -11.5% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2022 | Dec 31, 2022 | 33.9 | +64.6% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2021 | Dec 31, 2021 | 20.6 | -18.3% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2020 | Dec 31, 2020 | 25.2 | -11.6% | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
| FY2019 | Dec 31, 2019 | 28.5 | – | Vertex Pharmaceuticals (Europe) Limited (02907620) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Vertex Europe (UK) ($M), annual FY2019–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/uk-eur-lease-liab
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.
See a number that looks wrong?